UBE Corporation · TSE:4208
UBE — Q3 FY2017 Earnings Presentation
19 slides from UBE's earnings presentation, Feb 2, 2018
Slide 1: Financial Results for the 3rd Quarter FY 2017
1 Financial Results for the 3rd Quarter FY 2017 February 2, 2018 ※This"3rd Quarter(3Q)" date states information for 9 month total.
Slide 2: Scope of Consolidation
2 Scope of Consolidation - Financial Results for the 3rd Quarter FY2017 - End of FY2016 End of FY2017 3Q Difference Item Notes (A) (B) （B) - （A) Number of + UBE (Shanghai) LTD. consolidated 70 70 0 － Fukusei Tech Co.,Ltd subsidiaries Number of － UBE (Shanghai) LTD. equity method 25 24 -1 － Samekawa
Slide 3: Environmental Factors
3 Environmental Factors - Financial Results for the 3rd Quarter FY2017 - FY2016 3Q FY2017 3Q Difference Item (A) (B) (B) - (A) Exchange Rate Yen/$ 106.7 111.7 5.0 408 485 77 Naphtha CIF $/ｔ 32,200 39,600 7,400 Material Price Domestic Yen/KL Benzene(ACP) $/ｔ 648 794 146 Australian $/ｔ 77.9 102.7 24.8
Slide 4: Major P/L & B/S Items
4 Major P/L ＆ B/S Items - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2016 3Q FY2017 3Q Difference Item (A) (B) (B) - (A) Net sales 439.9 507.0 67.1 Operating profit 22.6 37.6 14.9 Ordinary profit 22.6 39.0 16.4 Profit attributable to owners of parent 15.0 26.6 11.5 End of FY2
Slide 5: Net Sales by Segment
5 Net Sales by Segment - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2016 3Q FY2017 3Q Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 16.6, Synthetic rubber 12.3, Chemicals 183.5 225.3 41.8 Battery Materials and Fine Chemicals 5.0, Polyimide and Spe
Slide 6: Operating Profit by Segment
6 Operating Profit by Segment - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2016 3Q FY2017 3Q Difference Segment Major factors (A) (B) (B) - (A) Nylon/Caprolactam chain 7.7, Synthetic rubber 5.4, Chemicals 4.4 22.1 17.7 Battery Materials and Fine Chemicals 1.4, Polyimide and S
Slide 7: Analysis of Operating Profit
7 Analysis of Operating Profit - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) Operating profit Variance Segment FY2016 3Q FY2017 3Q Difference Sales Fixed Price Others volume Cost (A) (B) (B) - (A) *1 *2 Chemicals 4.4 22.1 17.7 11.5 3.5 2.1 0.7 Pharmaceutical 1.6 1.4 -0.1 0.1 0.8
Slide 8: Non Operating Income/Expenses
8 Non Operating Income/Expenses - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2016 3Q FY2017 3Q Difference Item (A) (B) (B) - (A) Operating profit 22.6 37.6 14.9 Net interest expenses -0.3 0.0 0.3 Share of profit of entities income/expenses Non-operating accounted for using 1.
Slide 9: Extraordinary Income/Losses
9 Extraordinary Income/Losses - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2016 3Q FY2017 3Q Difference Item (A) (B) (B) - (A) Loss on disposal of PP&E -1.5 -0.9 0.5 Others 0.0 0.0 -0.0 Extraordinary income/losses -1.4 -0.9 0.5
Slide 10: Operating Profit - Net Income
10 Operating Profit - Net Income - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2016 3Q FY2017 3Q Difference Item (A) (B) (B) - (A) Operating profit 22.6 37.6 14.9 Non-operating income/expenses -0.0 1.4 1.5 Ordinary profit 22.6 39.0 16.4 Extraordinary income/losses -1.4 -0.9 0.
Slide 11: Consolidated Balance Sheet
11 Consolidated Balance Sheet - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) End of FY2016 End of FY2017 3Q Difference Item (A) (B) (B) - (A) Current assets 295.0 315.1 20.0 Fixed assets 414.2 419.5 5.3 Total assets 709.3 734.8 25.4 Interest-bearing debts 210.4 205.2 -5.2 Other l
Slide 12: Consolidated Statements of Cash Flows
12 Consolidated Statements of Cash Flows - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) Item FY2016 3Q FY2017 3Q Profit before income taxes 38.0, A.Cash flows from operating activities 28.1 42.5 Depreciation and amortization 26.1, Workig capital -9.3, etc. B.Cash flows from inves
Slide 13: Reference
13 Reference UBE
Slide 14: Reference: Progress of Major P/L Items
14 【Reference】 Progress of Major P/L Items - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2016 (A) FY2017 (B) Difference (B) - (A) 項 目 3Q 3Q 3Q （Progress） （Progress） 439.9 507.0 Net sales 616.5 685.0 68.5 67.1 (71.3%) (74.0%) 22.6 37.6 Operating profit 34.9 45.0 10.1 14.9 (64.9
Slide 15: Reference: Progress of Net Sales by Segment
15 【Reference】 Progress of Net Sales by Segment - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) Second half FY2017 Second half Full-year (Forecast) Segment Published (Progress) (Forecast) 1Q 2Q 3Q 4Q Total Oct 26, 2017 % Chemicals 73.3 72.9 79.0 - 225.3 149.0 53% 295.0 Pharmaceuti
Slide 16: Reference: Progress of Operating Profit by Segment
16 【Reference】 Progress of Operating Profit by Segment - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) Second half FY2017 Second half Full-year (Forecast) Segment Published (Progress) (Forecast) 1Q 2Q 3Q 4Q Total Oct 26, 2017 % Chemicals 6.1 7.1 8.8 - 22.1 10.2 86% 23.5 Pharmaceut
Slide 17: Reference: Consolidated Key Indicators
17 【Reference】 Consolidated Key Indicators - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) FY2017 full-year Item FY2016 3Q FY2017 3Q FY2016 full-year (forecast) Capital investment 26.6 24.0 42.0 44.0 Depreciation and amortization 25.4 26.1 35.0 34.4 R&D expenses 10.0 9.8 14.5 13.6
Slide 18: Reference: Major Subsidiaries
18 【Reference】 Major Subsidiaries - Financial Results for the 3rd Quarter FY2017 - (Billions of yen) Operating Sales Subsidiaries and affiliates Business profit Difference from FY2017 3Q FY2016 3Q UBE CHEMICALS (ASIA) PUBLIC CO., LTD Manufacture and sales of caprolactam, ammonium sulfate, and nylon
Slide 19: Forward-looking statements disclaimer
19 This presentation material contains forward-looking statements concerning UBE’s future plans, strategies, and performance. These forward-looking statements are not historical facts; rather, they represent assumptions and beliefs based on economic, financial, and competitive date currently availab